openPR Logo
Press release

Cardiology Genomic Testing Market Impact Analysis By 2028

02-21-2019 11:58 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Fact.MR

/ PR Agency: Fact.MR
Cardiology Genomic Testing Market Impact Analysis By 2028

Heart disorders can be inherited and passed from parents to children via their genes. Cardiology genomic testing helps in detecting diseases such as aortopathy and congenital heart diseases. Also, it can be useful for family members who are at a risk of developing heart problems. Genetic disorders affect the development of blood vessels and lead to heart diseases. Identification of genetic causes can save lives. The technology used for cardiology genomic testing is called NGS (Next generation Sequencing). The technology further reads the genetic content which helps in identifying the changes in DNA sequence. The mutations associated with heart conditions can occur due to pathogens.

Cardiology Genomic Testing Market: Drivers and Restraints

The growing prevalence of heart diseases such as cardiac arrhythmias and atherosclerosis is expected to be the major factor driving the growth of the cardiology genomic testing market over the forecast period. According to Invitae Corporation, more than 1 in 200 people have inherited some form of heart disease. Moreover, unhealthy lifestyle choices increase the risk of heart disease and this factor is driving the cardiology genomic testing market. Cardiology genomic testing helps in diagnosis, prognosis, and management of heart diseases. Cardiology genomic testing helps in identifying patients with a high risk of heart failure or arrhythmias. Also, the test differentiates and confirms the disease from other causes. Cardiology genomic testing also helps in directing treatment options which will avoid trigging cardiac events. Cardiology genomic testing kits provide rapid results and great efficiency. It also helps in reducing risks among patients. However, the number of genes vary with disorders. The overall cardiology genomic market testing is pushed by the growing expenditure on healthcare.

Get Free Exclusive Sample Copy of This Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=2565

Cardiology Genomic Testing Market: Overview

Cardiology genomic testing kits are used as a preventive healthcare diagnostic kit to save the lives of patients. According to the Center for Disease Control and Prevention, approximately 86 million people have at least one type of cardiovascular disease. Cardiology genomic testing kits are easy to use and the results are obtained within 4-8 weeks. The global market for cardiology genomic testing is expected to witness high growth over the forecast period. The cardiology genomic testing market is expected to increase with a rise in cardiac diseases among adults and children. Treatment is necessary for inherited and untreated heart conditions to further prevent serious problems such as heart attacks.

Cardiology Genomic Testing Market: Regional Outlook

Geographically, the global cardiology genomic testing market is segmented into North America, Latin America, Europe, Asia-Pacific excluding Japan (APEJ), Japan, and the Middle East and Africa (MEA). North America is expected to be the dominant market in the global cardiology genomic testing market owing to the increasing number of cardiac diseases. Also, the market in North America will rise due to the advancements in technology as well as strict regulations for patient care and safety in the region. The cardiology genomic testing market in the Asia Pacific excluding Japan is expected to grow at a significant CAGR due to the expansion of product offerings by the key players. In addition, cardiology genomic testing is contributing to the improvement of the health of the population by decreasing heart attack and congenital heart disease rates. Europe is expected to have the second largest share in the global cardiology genomic testing market throughout the forecast period. 

Request for table of content on this report visit:https://www.factmr.com/connectus/sample?flag=T&rep_id=2565

Cardiology Genomic Testing Market: Key Players

The global market for cardiology genomic testing is highly fragmented. Examples of some of the key players operating in cardiology genomic testing kits are Color Genomics, Inc. Thermo Fisher Scientific, Admera Health, Helix OpCo LLC, Blueprint Genetics Oy. Illumina, Inc., Gnome Diagnostics, Creative Diagnostics, Merck KGaA, MP Biomedicals, LLC., CENTOGENE AG, and Oasis Diagnostics Corporation among others. 

For more information on this report, please visit:https://www.factmr.com/report/2565/cardiology-genomic-testing-market

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: www.factmr.com/

Read Industrial News : http://insiderstribune.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cardiology Genomic Testing Market Impact Analysis By 2028 here

News-ID: 1606795 • Views:

More Releases from Fact.MR

Canine Stem Cell Therapy Market projected to reach US$ 300.1 million by 2034
06-20-2024 | Health & Medicine
Fact.MR
Canine Stem Cell Therapy Market projected to reach US$ 300.1 million by 2034
The global canine stem cell therapy market, projected to reach US$ 201.6 million by 2024, is expected to grow steadily at a compound annual growth rate (CAGR) of 4.1% from 2024 to 2034. This therapeutic approach harnesses the regenerative potential of a dog's own cells or those sourced from other origins to aid in healing processes. Conditions like arthritis and peripheral nerve damage among dogs can benefit significantly from this
Oral Solid Dosage Contract Manufacturing Market expected to achieve US$ 40,776.0 million by 2034.
06-20-2024 | Health & Medicine
Fact.MR
Oral Solid Dosage Contract Manufacturing Market expected to achieve US$ 40,776.0 …
The Oral Solid Dosage Contract Manufacturing Market is expected to achieve a value of US$ 26,457.9 million by 2024. Over the period from 2024 to 2034, a compound annual growth rate of 4.4% is anticipated for sales in oral solid dosage contract manufacturing. By 2034, it is projected that this market will expand to US$ 40,776.0 million. In the pharmaceutical industry, the Oral Solid Dosage (OSD) Contract Manufacturing Market is undergoing
Crohn's Disease Treatment Market Reaching A Valuation Of US$ 5,912.5 Million By 2034
06-20-2024 | Health & Medicine
Fact.MR
Crohn's Disease Treatment Market Reaching A Valuation Of US$ 5,912.5 Million By …
The global Crohn's Disease Treatment Market is currently valued at US$ 4,474.8 million, with an expected compound annual growth rate (CAGR) of 2.8%. By 2034, it is projected to reach US$ 5,912.5 million. The increasing prevalence of Crohn's disease worldwide is driving demand for effective treatments, thereby expanding the market. Ongoing research and development efforts have identified new therapeutic targets and introduced innovative treatment options. As a result, the variety of
Invisible Orthodontics Market to Reach USD 7.83 Billion by 2034 | Fact.MR
06-20-2024 | Health & Medicine
Fact.MR
Invisible Orthodontics Market to Reach USD 7.83 Billion by 2034 | Fact.MR
The invisible orthodontics market is projected to reach US$ 4,001.2 million by 2024 and is expected to grow steadily at a compound annual growth rate (CAGR) of 5.2% from 2024 to 2034. By 2034, the market is anticipated to surpass US$ 6,648.7 million. A key driver of this growth is increasing awareness among the population about the potential adverse effects of untreated dental misalignments, including compromised oral health and diminished self-confidence.

All 5 Releases


More Releases for Cardiology

Cardiology Conference 2022
Theme: "Exploring New Research and Frontiers in Heart Care" Heart 2022 welcomes all the eminent professional scholars, researchers and beloved students to be a part of this “INTERNATIONAL CONFERENCE ON CLINICAL CARDIOLOGY & CONGENITAL HEART DISEASE” scheduled on FEBRUARY 07-08, 2022 | PARIS | FRANCE. With individuals from around the world zeroed in on finding a few solutions concerning Cardiology, this is your single most clear chance to achieve the best
World Cardiology Congress
Herald Meetings welcomes you to join World Cardiology Congress scientific symposium will be held in Prague, Czech Republic during August 26 to 27, 2020 About Conferences: WORLD CARDIOLOGY CONGRESS, scheduled on August 26-27, 2020 at Prague, Czech Republic. The conference strives to provide meaningful coverage on the theme "Prediction, Prevention and Cure of Cardiovascular Diseases". Cardiology Congress has established itself as a significant forum for Professors, Cardiology Specialists, Eminent Scientists, and Vascular surgeons,
25th World Cardiology Conference
Conference series proudly announces the “25th World Cardiology Conference” which will be held during July 10-11, 2019 at Osaka, Japan. The theme of conference is “New Insights in Cardiology for a diverse World”. Cardiology Congress 2019 Conference will be an investigation of new research Innovation in the field of Cardiology and spread the most recent advancements in heart disease prevention and rehabilitation. Discussion on new technology advancement in the field
Cardiology Surgery, Devices and Drugs Market Report 2018: Segmentation by Type ( …
Global Cardiology Surgery, Devices and Drugs market research report provides company profile for St. Jude Medical, Cook Medical, C. R. Bard, Sun Pharmaceutical, Pfizer, Sanofi, AstraZeneca, Novartis, Bristol-Myers Squibb, Merck, Boston Scientific, Medtronic and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and
27th European Cardiology Conference
27th European Cardiology Conference Details: With the successful completion of 20th European Cardiology Conference, the Cardiology Conferences in 2018 meet is proud to announce that its 3 day 27th European Cardiology Conference (Euro Cardiology 2018) will be held in Rome, Italy during October 22-24, 2018.The conference will be the world’s best platform for all the cardiologists, cardiac surgeons, medical practitioners, research scholars and clinical research organizations to encourage and explore the modern
19th Annual Cardiology
19th Annual Cardiology Conference to be held in Philadelphia, USA during August 31-September 1, 2017 Annual Cardiology 2017 will bring together world-class cardiac professors, cardiac surgeons, cardiologists to discuss strategies for remediation of the disease for the heart, cardiac disorders, research on stem cells in cardiology, cardiac enzyme studies. Cardiology conferences are designed to provide a diversified education and present that will keep medical professionals informed of issues related to